Literature DB >> 17066036

Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages.

Kohki Kawane1, Mayumi Ohtani, Keiko Miwa, Takuji Kizawa, Yoshiyuki Kanbara, Yoshichika Yoshioka, Hideki Yoshikawa, Shigekazu Nagata.   

Abstract

A large amount of chromosomal DNA is degraded during programmed cell death and definitive erythropoiesis. DNase II is an enzyme that digests the chromosomal DNA of apoptotic cells and nuclei expelled from erythroid precursor cells after macrophages have engulfed them. Here we show that DNase II-/-IFN-IR-/- mice and mice with an induced deletion of the DNase II gene develop a chronic polyarthritis resembling human rheumatoid arthritis. A set of cytokine genes was strongly activated in the affected joints of these mice, and their serum contained high levels of anti-cyclic citrullinated peptide antibody, rheumatoid factor and matrix metalloproteinase-3. Early in the pathogenesis, expression of the gene encoding tumour necrosis factor (TNF)-alpha was upregulated in the bone marrow, and administration of anti-TNF-alpha antibody prevented the development of arthritis. These results indicate that if macrophages cannot degrade mammalian DNA from erythroid precursors and apoptotic cells, they produce TNF-alpha, which activates synovial cells to produce various cytokines, leading to the development of chronic polyarthritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17066036     DOI: 10.1038/nature05245

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  187 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 2.  Role of the nucleus in apoptosis: signaling and execution.

Authors:  Evgeniia A Prokhorova; Alexey V Zamaraev; Gelina S Kopeina; Boris Zhivotovsky; Inna N Lavrik
Journal:  Cell Mol Life Sci       Date:  2015-09-07       Impact factor: 9.261

Review 3.  AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunity.

Authors:  Si Ming Man; Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2015-12-28       Impact factor: 5.532

Review 4.  AIM2 in health and disease: Inflammasome and beyond.

Authors:  Puja Kumari; Ashley J Russo; Sonia Shivcharan; Vijay A Rathinam
Journal:  Immunol Rev       Date:  2020-07-26       Impact factor: 12.988

5.  Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation.

Authors:  Kohki Kawane; Hiromi Tanaka; Yusuke Kitahara; Shin Shimaoka; Shigekazu Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

Review 6.  Innate and adaptive immune response to apoptotic cells.

Authors:  Yufeng Peng; David A Martin; Justin Kenkel; Kang Zhang; Carol Anne Ogden; Keith B Elkon
Journal:  J Autoimmun       Date:  2007-09-20       Impact factor: 7.094

7.  The phylogeny and evolution of deoxyribonuclease II: an enzyme essential for lysosomal DNA degradation.

Authors:  Max Shpak; Jeffrey R Kugelman; Armando Varela-Ramirez; Renato J Aguilera
Journal:  Mol Phylogenet Evol       Date:  2007-12-14       Impact factor: 4.286

Review 8.  Extracellular DNA and autoimmune diseases.

Authors:  Hantao Lou; Matthew C Pickering
Journal:  Cell Mol Immunol       Date:  2018-03-19       Impact factor: 11.530

Review 9.  Phagosome maturation: going through the acid test.

Authors:  Jason M Kinchen; Kodi S Ravichandran
Journal:  Nat Rev Mol Cell Biol       Date:  2008-10       Impact factor: 94.444

10.  Extrachromosomal histone H2B mediates innate antiviral immune responses induced by intracellular double-stranded DNA.

Authors:  Kouji Kobiyama; Fumihiko Takeshita; Nao Jounai; Asako Sakaue-Sawano; Atsushi Miyawaki; Ken J Ishii; Taro Kawai; Shin Sasaki; Hisashi Hirano; Norihisa Ishii; Kenji Okuda; Koichi Suzuki
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.